Microsoft has released ASP.NET Core in .NET 11 Preview 1, introducing new Blazor components like EnvironmentBoundary, Label, and DisplayName, along with relative URI navigation, QuickGrid row click ...

A ransom note was sent to a local Arizona news station after the disappearance of Today show co-host Savannah Guthrie’s mom, Nancy Guthrie. Savannah Guthrie, who has helmed the show as a co-anchor for ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Major iPhone updates like iOS 26 typically come with hundreds of new features and changes, but a much smaller subset that become daily go-tos. Here are four new iOS 26 features I’ve found myself using ...

There’s a reason sticky notes are a staple in offices, dorm rooms, books and so many other places. They’re incredibly convenient when you need to quickly jot something down and stick it somewhere ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...